Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Infants expected to need prolonged PN (receiving \>75% PN on dol 7) with the following risk factors:~   1. Prematurity with gestational age (GA) \<32 weeks AND birth weight \<1500g. OR~  2. Congenital anomaly of the gastrointestinal tract regardless of GA or BW~2. Screening direct bilirubin prior to the initiation of parenteral nutrition \<2mg/dL.~Exclusion Criteria:~1. Infants with major congenital anomalies, other than those of the gastrointestinal tract.~2. Infants with known obstruction of the hepatobiliary tract.~3. Infants with suspected congenital infection or suspected genetic/metabolic syndrome predisposing them to cholestasis based on direct bilirubin \> 2mg/dL prior to instituting PN.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 7 Days
- Healthy Volunteers: f

Study Arms:
- Cycling Parenteral Nutrition (Type: EXPERIMENTAL): Infants in the intervention cycling group will receive infusion of carbohydrate/amino acids and intralipid over a 20-hour period. During the 4-hour window period, infants in this group will receive dextrose solution only at the same rate calculated for the carbohydrate/amino acid infusion.
- Continuous Parenteral Nutrition (Type: ACTIVE_COMPARATOR): Infants in this control group will receive infusion of carbohydrates/amino acids and intralipids continuously, over 24 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).